Literature DB >> 1925759

Radiographic and histologic effects of chondroitinase ABC on normal canine lumbar intervertebral disc.

T R Fry1, J C Eurell, A L Johnson, M D Brown, J M Losonsky, D J Schaeffer.   

Abstract

Twelve dogs were divided into two equal groups and given lumbar intradiscal injections of 10, 50, or 100 U/ml of chondroitinase ABC reconstituted in sodium acetate buffer. Radiographs of the lumbar spine were made before and after surgery in both groups. Additional films were made at 5 days after surgery in Group I and at 7, 14, and 21 days after surgery in Group II. All spaces injected with 50 or 100 U/ml chondroitinase ABC demonstrated significant radiographic narrowing in both groups compared with uninjected control and buffer injected discs (P less than 0.001). Discs injected with 10 U/ml of chondroitinase ABC showed increased narrowing over time from 7 to 21 days (P less than 0.05). A zone of safranin O depletion was present in the ventral anulus fibrosus adjacent to the nucleus pulposus in all treated discs, indicating proteoglycan loss. All histologic effects of chondroitinase ABC were confined to intervertebral disc tissues. Chondroitinase ABC appears to be effective for chemonucleolysis in dogs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925759     DOI: 10.1097/00007632-199107000-00022

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  8 in total

1.  CT-guided injection technique into intervertebral discs in the ovine lumbar spine.

Authors:  Jean Francois Nisolle; Fabienne Neveu; Fanny Hontoir; Peter Clegg; Nathalie Kirschvink; Jean-Michel Vandeweerd
Journal:  Eur Spine J       Date:  2013-08-11       Impact factor: 3.134

2.  The effect of chondroitinase ABC on rabbit intervertebral disc. Radiological, histological and electron microscopic findings.

Authors:  J S Park; J I Ahn
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

Review 3.  Emerging technologies for molecular therapy for intervertebral disk degeneration.

Authors:  Won C Bae; Koichi Masuda
Journal:  Orthop Clin North Am       Date:  2011-10       Impact factor: 2.472

4.  A longitudinal study on an autoimmune murine model of ankylosing spondylitis.

Authors:  T Bárdos; Z Szabó; M Czipri; C Vermes; M Tunyogi-Csapó; R M Urban; K Mikecz; T T Glant
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

Review 5.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

6.  A large animal model that recapitulates the spectrum of human intervertebral disc degeneration.

Authors:  S E Gullbrand; N R Malhotra; T P Schaer; Z Zawacki; J T Martin; J R Bendigo; A H Milby; G R Dodge; E J Vresilovic; D M Elliott; R L Mauck; L J Smith
Journal:  Osteoarthritis Cartilage       Date:  2016-08-26       Impact factor: 6.576

Review 7.  Biological repair of the degenerated intervertebral disc by the injection of growth factors.

Authors:  Koichi Masuda
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

8.  BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.

Authors:  Balint Farkas; Ferenc Boldizsar; Oktavia Tarjanyi; Anna Laszlo; Simon M Lin; Gabor Hutas; Beata Tryniszewska; Aaron Mangold; Gyorgy Nagyeri; Holly L Rosenzweig; Alison Finnegan; Katalin Mikecz; Tibor T Glant
Journal:  Arthritis Res Ther       Date:  2009-02-16       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.